The University of Texas Medical Branch has announced a groundbreaking collaboration with NIPOKA, a leading German-based company specializing in advanced diagnostic technologies for kidney research. With over 35 million adults in the U.S. affected by chronic kidney disease, and millions more worldwide, the need for accurate diagnostics has never been more critical. This partnership aims to develop first-of-its-kind diagnostic tests that could transform the way kidney patients are diagnosed, treated, and monitored.